×
About 15,562 results

ALLMedicine™ Epstein-barr Virus Center

Research & Reviews  7,685 results

Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on n...
https://doi.org/10.1016/j.intimp.2021.107829
International Immunopharmacology; Chen M, Jiang Y et. al.

Jun 13th, 2021 - Nasal natural killer/T-cell lymphoma (NNKTL) is an aggressive and poor prognostic malignant tumor along with high-level infection of Epstein-Barr virus (EBV). Gemcitabine (Gem) and Thymosin alpha 1 (Tα1) exert an anti-tumor effect in various cance...

Termination of Pregnancy Services in Irish General Practice from January 2019 to June 2...
https://doi.org/10.1016/j.contraception.2021.05.021
Contraception Horgan P, Thompson M et. al.

Jun 12th, 2021 - Epstein-Barr virus (EBV) causes endemic Burkitt lymphoma (eBL). EBV control was improved by magnesium (Mg2+) supplementation in XMEN, an X-linked genetic disease associated with Mg2+ deficiency, high circulating EBV levels (viral loads), and EBV-r...

NK-/T-cell lymphomas.
https://doi.org/10.1038/s41375-021-01313-2 10.1080/17474086.2016.1206465 10.3324/haematol.2017.180430 10.1016/j.humpath.2015.03.002 10.1182/blood-2016-01-643569 10.1186/s13045-018-0687-0 10.1182/blood-2012-05-431460 10.1016/j.pathol.2019.09.011 10.1038/nm.4456 10.1182/blood-2003-05-1401 10.1007/s12185-012-1174-y 10.1038/s41375-020-0740-1 10.3109/10428194.2015.1037764 10.4143/crt.2019.198 10.1182/blood-2019-123446 10.1007/s00262-017-1987-x 10.1038/mt.2015.91 10.1186/1750-1172-8-95 10.1002/ijc.2910440112 10.3109/10428199809050934 10.1128/JVI.77.21.11507-11516.2003 10.1097/PAS.0b013e31821ec4b5 10.1038/s41379-019-0415-5 10.1016/S1470-2045(19)30799-5 10.1128/JVI.03614-14 10.1002/jmv.20129 10.1002/jmv.24190 10.1002/ijc.30128 10.1111/cas.13954 10.1128/JVI.79.24.15323-15330.2005 10.1128/JVI.00823-11 10.1016/j.celrep.2013.09.012 10.1002/jmv.24633 10.1371/journal.pone.0027805 10.1016/j.virol.2006.01.015 10.1128/JVI.02517-12 10.1128/JVI.01665-14 10.1038/srep16706 10.1002/(SICI)1097-0215(19990129)80:3<356::AID-IJC4>3.0.CO;2-D 10.1038/s41375-018-0324-5 10.1016/S0046-8177(99)90147-8 10.1016/S1470-2045(16)30148-6 10.1038/nri3044 10.1097/PAS.0b013e31824433d8 10.1038/nri1570 10.1016/j.humpath.2014.11.008 10.1186/s13045-017-0452-9 10.1182/blood-2005-05-2056 10.1371/journal.pone.0130984 10.1038/leu.2013.212 10.1016/S2352-3026(15)00002-2 10.1182/blood-2015-07-655191 10.1200/JCO.2005.04.1384 10.1056/NEJM199309303291402 10.1016/S1470-2045(15)00533-1 10.1038/leu.2015.44 10.1001/jamanetworkopen.2019.0194 10.1200/JCO.2005.03.2573 10.1200/JCO.2000.18.1.54 10.1080/10428194.2019.1599111 10.1200/JCO.2009.23.8295 10.1200/JCO.2012.45.6541 10.1016/j.ejca.2015.07.009 10.1111/ejh.12405 10.1200/JCO.2009.23.8592 10.1007/s00277-014-2137-6 10.1002/ijc.33329 10.1016/j.ebiom.2017.10.011 10.1002/cncr.27752 10.3892/ol.2015.3327 10.1200/JCO.2011.35.6287 10.1038/bcj.2017.88 10.1182/blood-2010-09-307454 10.18632/oncotarget.8647 10.1097/MD.0000000000002787 10.1158/1078-0432.CCR-16-0153 10.1093/annonc/mdx684 10.7150/jca.24310 10.1016/j.bbmt.2015.05.003 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1 10.1080/10428190410001693524 10.1186/s40880-018-0334-8 10.1002/jcb.28529 10.1002/ajh.21811 10.1080/10428194.2018.1480772 10.1080/15384047.2017.1295176 10.1159/000500974 10.1182/blood-2016-12-756841 10.1186/s13045-018-0559-7 10.4143/crt.2018.191 10.1007/s00277-017-3127-2 10.1182/blood-2020-136949 10.1182/blood-2019-121865 10.1007/s00277-015-2359-2 10.1186/s40880-017-0212-9 10.1056/NEJMc1605684 10.5045/br.2015.50.4.254 10.1007/s00277-016-2627-9 10.1182/blood-2018-10-878587 10.1093/annonc/mdv237 10.1186/s13045-017-0439-6 10.1182/blood.V130.Suppl_1.945.945 10.1182/blood-2020-134665 10.1093/annonc/mdw231 10.1200/JCO.2011.37.4223 10.1182/blood.2019001285 10.1200/JCO.2014.59.2782 10.1182/blood-2017-09-806737 10.1182/blood.V128.22.2991.2991 10.1111/cas.12418 10.1111/j.1349-7006.2011.02127.x
Leukemia Wang H, Fu BB et. al.

Jun 12th, 2021 - Natural killer/T-cell lymphoma (NKTL) is a sub-type of Epstein-Barr virus (EBV)-related non-Hodgkin lymphomas common in Asia and Latin America but rare elsewhere. Its pathogenesis is complex and incompletely understood. Lymphoma cells are transfor...

Clinical features of NK/T-cell EBV-associated LPD manifested as gastrointestinal sympto...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191100
BMC Gastroenterology; Wang SZ, Dai YH et. al.

Jun 11th, 2021 - Epstein-Barr virus (EBV)-associated NK/T-cell lymphoproliferative disorder (LPD) involving the gastrointestinal tract is rarely observed in individuals with normal immunity. The atypical clinical, colonoscopic manifestations often confuse clinicia...

Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis - ...
https://doi.org/10.1111/ene.14961
European Journal of Neurology; Grut V, Biström M et. al.

Jun 9th, 2021 - Epstein-Barr virus (EBV) and Human herpesvirus 6A (HHV-6A) are associated with increased risk of multiple sclerosis (MS). Conversely, infection with Cytomegalovirus (CMV) has been suggested to reduce the risk of MS but supporting data from presymp...

see more →

Guidelines  1 results

Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329850/
BioMed Research International;

Jan 30th, 2015 - Multiple sclerosis (MS) is a chronic central nervous system disease with a highly heterogeneous course. The aetiology of MS is not well understood but is likely a combination of both genetic and environmental factors. Approximately 85% of patients...

see more →

Drugs  21 results see all →

Clinicaltrials.gov  7,773 results

Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on n...
https://doi.org/10.1016/j.intimp.2021.107829
International Immunopharmacology; Chen M, Jiang Y et. al.

Jun 13th, 2021 - Nasal natural killer/T-cell lymphoma (NNKTL) is an aggressive and poor prognostic malignant tumor along with high-level infection of Epstein-Barr virus (EBV). Gemcitabine (Gem) and Thymosin alpha 1 (Tα1) exert an anti-tumor effect in various cance...

Termination of Pregnancy Services in Irish General Practice from January 2019 to June 2...
https://doi.org/10.1016/j.contraception.2021.05.021
Contraception Horgan P, Thompson M et. al.

Jun 12th, 2021 - Epstein-Barr virus (EBV) causes endemic Burkitt lymphoma (eBL). EBV control was improved by magnesium (Mg2+) supplementation in XMEN, an X-linked genetic disease associated with Mg2+ deficiency, high circulating EBV levels (viral loads), and EBV-r...

NK-/T-cell lymphomas.
https://doi.org/10.1038/s41375-021-01313-2 10.1080/17474086.2016.1206465 10.3324/haematol.2017.180430 10.1016/j.humpath.2015.03.002 10.1182/blood-2016-01-643569 10.1186/s13045-018-0687-0 10.1182/blood-2012-05-431460 10.1016/j.pathol.2019.09.011 10.1038/nm.4456 10.1182/blood-2003-05-1401 10.1007/s12185-012-1174-y 10.1038/s41375-020-0740-1 10.3109/10428194.2015.1037764 10.4143/crt.2019.198 10.1182/blood-2019-123446 10.1007/s00262-017-1987-x 10.1038/mt.2015.91 10.1186/1750-1172-8-95 10.1002/ijc.2910440112 10.3109/10428199809050934 10.1128/JVI.77.21.11507-11516.2003 10.1097/PAS.0b013e31821ec4b5 10.1038/s41379-019-0415-5 10.1016/S1470-2045(19)30799-5 10.1128/JVI.03614-14 10.1002/jmv.20129 10.1002/jmv.24190 10.1002/ijc.30128 10.1111/cas.13954 10.1128/JVI.79.24.15323-15330.2005 10.1128/JVI.00823-11 10.1016/j.celrep.2013.09.012 10.1002/jmv.24633 10.1371/journal.pone.0027805 10.1016/j.virol.2006.01.015 10.1128/JVI.02517-12 10.1128/JVI.01665-14 10.1038/srep16706 10.1002/(SICI)1097-0215(19990129)80:3<356::AID-IJC4>3.0.CO;2-D 10.1038/s41375-018-0324-5 10.1016/S0046-8177(99)90147-8 10.1016/S1470-2045(16)30148-6 10.1038/nri3044 10.1097/PAS.0b013e31824433d8 10.1038/nri1570 10.1016/j.humpath.2014.11.008 10.1186/s13045-017-0452-9 10.1182/blood-2005-05-2056 10.1371/journal.pone.0130984 10.1038/leu.2013.212 10.1016/S2352-3026(15)00002-2 10.1182/blood-2015-07-655191 10.1200/JCO.2005.04.1384 10.1056/NEJM199309303291402 10.1016/S1470-2045(15)00533-1 10.1038/leu.2015.44 10.1001/jamanetworkopen.2019.0194 10.1200/JCO.2005.03.2573 10.1200/JCO.2000.18.1.54 10.1080/10428194.2019.1599111 10.1200/JCO.2009.23.8295 10.1200/JCO.2012.45.6541 10.1016/j.ejca.2015.07.009 10.1111/ejh.12405 10.1200/JCO.2009.23.8592 10.1007/s00277-014-2137-6 10.1002/ijc.33329 10.1016/j.ebiom.2017.10.011 10.1002/cncr.27752 10.3892/ol.2015.3327 10.1200/JCO.2011.35.6287 10.1038/bcj.2017.88 10.1182/blood-2010-09-307454 10.18632/oncotarget.8647 10.1097/MD.0000000000002787 10.1158/1078-0432.CCR-16-0153 10.1093/annonc/mdx684 10.7150/jca.24310 10.1016/j.bbmt.2015.05.003 10.1002/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1 10.1080/10428190410001693524 10.1186/s40880-018-0334-8 10.1002/jcb.28529 10.1002/ajh.21811 10.1080/10428194.2018.1480772 10.1080/15384047.2017.1295176 10.1159/000500974 10.1182/blood-2016-12-756841 10.1186/s13045-018-0559-7 10.4143/crt.2018.191 10.1007/s00277-017-3127-2 10.1182/blood-2020-136949 10.1182/blood-2019-121865 10.1007/s00277-015-2359-2 10.1186/s40880-017-0212-9 10.1056/NEJMc1605684 10.5045/br.2015.50.4.254 10.1007/s00277-016-2627-9 10.1182/blood-2018-10-878587 10.1093/annonc/mdv237 10.1186/s13045-017-0439-6 10.1182/blood.V130.Suppl_1.945.945 10.1182/blood-2020-134665 10.1093/annonc/mdw231 10.1200/JCO.2011.37.4223 10.1182/blood.2019001285 10.1200/JCO.2014.59.2782 10.1182/blood-2017-09-806737 10.1182/blood.V128.22.2991.2991 10.1111/cas.12418 10.1111/j.1349-7006.2011.02127.x
Leukemia Wang H, Fu BB et. al.

Jun 12th, 2021 - Natural killer/T-cell lymphoma (NKTL) is a sub-type of Epstein-Barr virus (EBV)-related non-Hodgkin lymphomas common in Asia and Latin America but rare elsewhere. Its pathogenesis is complex and incompletely understood. Lymphoma cells are transfor...

Clinical features of NK/T-cell EBV-associated LPD manifested as gastrointestinal sympto...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191100
BMC Gastroenterology; Wang SZ, Dai YH et. al.

Jun 11th, 2021 - Epstein-Barr virus (EBV)-associated NK/T-cell lymphoproliferative disorder (LPD) involving the gastrointestinal tract is rarely observed in individuals with normal immunity. The atypical clinical, colonoscopic manifestations often confuse clinicia...

Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis - ...
https://doi.org/10.1111/ene.14961
European Journal of Neurology; Grut V, Biström M et. al.

Jun 9th, 2021 - Epstein-Barr virus (EBV) and Human herpesvirus 6A (HHV-6A) are associated with increased risk of multiple sclerosis (MS). Conversely, infection with Cytomegalovirus (CMV) has been suggested to reduce the risk of MS but supporting data from presymp...

see more →

News  81 results

Schizophrenia patients have ‘aberrant’ response to Epstein-Barr
https://www.mdedge.com/psychiatry/article/210181/schizophrenia-other-psychotic-disorders/schizophrenia-patients-have?channel=293
Christopher Palmer

Oct 15th, 2019 - Individuals with schizophrenia had elevated levels of one Epstein-Barr virus (EBV) antibody but atypically low levels of another, which investigators deemed an “aberrant immune response. ” Faith Dickerson, PhD, MPH, Lorraine Jones-Brando, PhD,and c.

Vitamin D Boosts, Smoking Clouds Cognition in MS
https://www.medscape.com/viewarticle/903457

Oct 14th, 2018 - BERLIN — Higher vitamin D levels at the time of a diagnosis of a clinically isolated syndrome (CIS) were associated with better cognitive performance 11 years later. In contrast, cigarette smoking was linked to worse long-term cognition. Seroposit...

Epstein-Barr ‘Switches On” Autoimmune Genes
https://www.mdedge.com/fedprac/article/168262/mixed-topics/epstein-barr-switches-autoimmune-genes

Jun 16th, 2018 - The Epstein-Barr virus (EBV) protein can “switch on” risk genes for autoimmune diseases, according to researchers from the National Institute of Allergy and Infectious Diseases. They found that when EBV infects human immune cells, the virus produc.

Mortality in patients with PTLD
https://www.mdedge.com/hematology-oncology/article/185058/transplantation/mortality-patients-ptld
HT Staff

Mar 25th, 2018 - Benjamin Chaigne-Delalande Cell infected with Epstein-Barr virus (green/red) among uninfected cells (blue) Image courtesy of LISBON—A review of recent studies has revealed a “significant burden” of mortality related to post-transplant lymphoprolif.

Mono May Boost MS Risk
https://www.medpagetoday.com/neurology/multiplesclerosis/67624

Aug 30th, 2017 - Action Points Patients who have had mononucleosis due to infection with Epstein-Barr virus (EBV) may be at increased risk of multiple sclerosis (MS). Note that the data support the hygiene hypothesis: that being born/spending your early childhood ...

see more →

Patient Education  1 results see all →